Pancreatic Cancer

Questions discussed in this category

How would you treat single celiac focus of adenocarcinoma of unknown primary?

Would you consider SBRT as post-chemo consolidation for a patient with a single unresectable focus of metastatic adenocarcinoma at the celiac axis?&nb...

1 Answer available

What is your preferred first line regimen for a patient with BRCA+ metastatic pancreatic cancer with poor performance status?

2 Answers available

What third line treatment do you consider for a patient with metastatic pancreatic cancer with good functional status and no targetable mutations after progression on FOLFIRINOX and gemcitabine/nab-paclitaxel?

3 Answers available

Papers discussed in this category

N. Engl. J. Med., 2019 Jun 02

Maintenance Olaparib for Germline -Mutated Metastatic Pancreatic Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015-01-20

Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation.

Pancreatology, 2020 Oct 18

Nanoliposomal irinotecan (Nal-IRI)-based chemotherapy after irinotecan -based chemotherapy in patients with pancreas cancer.

Lancet (London, England), 2016-02-06

Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial.

European journal of cancer (Oxford, England : 1990), 2019-02

NAPOLI-1 phase 3 study of liposomal irinotecan in metastatic pancreatic cancer: Final overall survival analysis and characteristics of long-term survivors.

Pancreatic Cancer

Questions discussed in this category

Papers discussed in this category

Related Topics